A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...
The Medicare agency will extend a short-term program that will pay for weight-loss drugs such as Eli Lilly’s Zepbound and Novo Nordisk’s NOVO.B1.71%increase; green up pointing triangle Wegovy, ...
The Centers for Medicare & Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of the Medicare Drug Price Negotiation Program. These are high-cost drugs covered ...
Forbes contributors publish independent expert analyses and insights. I am a cable news contributor and professor of journalism. This voice experience is generated by AI. Learn more. This voice ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
Your editorial “The Great 340B Healthcare Grift” (May 8) highlights a program that has strayed far from its original mission. While drug therapies are essential to cancer care, access to these ...
February 26, 2026 - A newly released advisory by the U.S. Department of Health and Human Services' Office of Inspector General (HHS OIG) on how direct-to-consumer (DTC) prescription drug programs ...
Navigating drug coverage demands brain power in our DIY retirement system, and it isn’t getting any easier. While President Donald Trump has launched TrumpRx and other initiatives to lower costs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results